CLINICAL_TRIALS
trial_result
· 2013-11-25
Clinical Trial Update: Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia [Phase 3]
Summary
Phase 3 trial comparing ferric carboxymaltose to standard of care in iron deficiency anemia completed; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American Regent, Inc. | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25